Antibiotics, structurally changed

Daunorubicin is an anthracycline that is sometimes referred to as an antitumor antibiotic. Daunorubicin inserts between base pairs of DNA to cause structural changes in DNA however, the primary mechanism of cytotoxicity is the inhibition of topoisomerase II. The pharmacokinetics are best described by a two-compartment model, with a terminal half-life of about 20 hours. The predominant route of elimination of daunorubicin and hydroxylated metabolites is hepatobiliary... 

He discovered completely new nucleoslde-llke antitumor antibiotic containing a new heteroaromatic ring and named it oxano-sine (37) (Fig. 16). We found a dyneimic structural change of oxanosine with base and acid as shown in Fig. 16. On the basis of this finding, oxanosine was synthesized (86). This antibiotic produced a significant prolongation of the survival period in mice... 

B. Humans cannot synthesize folic acid (A) diet is their main source. Sulfonamides selectively inhibit microbially synthesized folic acid. Incorporation (B) of PABA into microbial folic acid is competitively inhibited by sulfonamides. The TMP-SMX combination is synergistic because it acts at different steps in microbial folic acid synthesis. All sulfonamides are bacteriostatic. Inhibition of the transpeptidation reaction (C) involved in the synthesis of the bacterial cell wall is the basic mechanism of action of (3-lac-tam antibiotics Changes in DNA gyrases (D) and active efflux transport system are mechanisms for resistance to quinolones. Structural changes (E) in dihydropteroate synthetase and overproduction of PABA are mechanisms of resistance to the sulfonamides. 

We now proceed to more complicated ionophores in order to testify the validity of this extrathermodynamic relationship and its hypothetical interpretation as an attempt to understand the nature of supramolecular interactions more generally and deeply. The thermodynamic parameters are plotted in Figures 16-19 for long glymes, (pseudo)cyclic ionophore antibiotics, lariat ethers with donating side-arm(s), and bis(crown ethers), whose structural changes upon complexation are schematically illustrated in Figure 20. 

Several hundred semisynthetic derivatives have been prepared in an effort to obtain substances with better biological activities (for references see Ref.s)). Particularly positions 3 and 4 of the naphthoquinone ring system (numbering system as proposed by Prelog7 8) have been extensively substituted, since it has been shown that structural changes in these two positions do not critically affect the action of the substance on the target enzyme, the bacterial RNA polymerase (cf. Chapter 3.). They can, however, influence other parameters such as its ability to penetrate into cells, its pharmacokinetic properties and resorption, which are all important for clinical use as an antibiotic. Rifampicin (U.S. rifampin), which is a widely used orally active tuberculostatic agent, is a 3-(4-methyl piperazinyl)-iminomethyl derivative of rifamycin SV, synthesized via the 3-formyl derivative (Fig. 5)10 ... 

The possible effects of such modifications are of several kinds, some not directly concerned with therapeutic efficacy. In its new form the antibiotic may be more stable, more soluble, more palatable (chloramphenicol palmitate), better absorbed (erythromycin estolate), or less irritant to the tissues (polymyxin methane sulfonate). Some of the most far-reaching effects produced by a minor structural change are seen in demethylchlortetracycline, which, as compared with tetracycline, is more stable, antibacterially more active, and much more slowly excreted. 

In principle, biosynthetic methods can provide structural variants that are inaccessible or very difficultly accessible by chemical methods on the other hand, except where incorporation of a wide variety of precursors is possible these methods do not now provide a means for directly making pre-selected changes in structure. Enzymatic or microbiological transformation of antibiotics is a related approach that in principle can bring about selective and specific structural changes. Although this method was used with success in the steroid field, it has not yet provided... 

Hochlowski, J. E, Whittern, D. N., Hill, P., and McAlpine, J. B. (1994) Dorrigocins novel antifungal antibiotics that change the morphology of rag-transformed NW3T3 cells to that of normal cells II. Isolation and elucidation of structures. J. Antibiotics 47, 870-874. 

In a number of cases, microbial resistance is mediated by the production of bacterial enzymes that attack the antibiotic molecule, changing its structure to an inactive form. This can lead to a so-called inoculum effect, in which a susceptible antibiotic is apparently less potent when larger numbers of bacteria are present in the medium than when fewer cells are employed. The more bacteria that are present, the more antibiotic-destroying enzyme that is present, and the more antibiotic that is required to overcome this to achieve the desired response. An antibiotic that is not enzyme modified is comparatively free of inoculum effects. 

Self-resistance. When the structure of the antibiotic is changed, the selfresistance mechanism of the host may no longer be able to provide protection from the new molecule (e.g., 1-hydroxyl aminoglycosides). 

Substances of the amphotericin D (a polyene), polyether (for example crown cyclic ethers), Antamanide (a peptide), and valinomycin (a depsi-peptide) represent structural types capable of complexing with alkali metal ions and thereby promoting their dissolution in fairly nonpolar solvents. Such compounds are known as ion carriers and some display antibiotic properties which may in part reside with activity in natural membranes. In order to evaluate structural changes upon such interesting functions, Gisin and Merri-field have synthesized a cyclododecapeptide (Chart 15) where the D-a-hy-droxyisovaleric acid and L-lactic acid units of valinomycin were replaced respectively with D-Pro and L-Pro. In MeCl-Aq the valinomycin analog was found to exhibit a seven times greater affinity for potassium picrate (to form a 1 1 hydrophobic complex) than that of the parent depsipeptide. 

---